This study showed that high glucose could affect the expression of lncRNA MEG3 and govern the miR-483-3p/ERp29 proteins in HCC patients, suggesting that management of lncRNA MEG3 could be promising for the treatment of HCC patients with diabetes (126). The gene discussed is ERP29; the disease is hepatocellular carcinoma.